Condition: Cardiac Arrythmias · Sponsor: Boston Scientific Corporation
The objective of the RHAPSODY study is to evaluate the performance of new software features in subjects undergoing standard of care catheter-based endocardial mapping for atrial or ventricular tachyarrhythmias using a commercial Rhythmia Mapping System. Results from this study will be used to guide development and refinement of new software features that may be implemented in future commercial software releases.
This description comes directly from the study's public registry record.
Susan Hampson · 5087285165 · Susan.Hampson@bsci.com
Always discuss trial participation with your own doctor first.
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Completed |
| St. Lukes Idaho Cardiology Associates | Boise, Idaho, United States | Completed |
| Lahey Clinic, Inc. | Burlington, Massachusetts, United States | Completed |
| Cardiovascular Specialists of New England Research Foundation | Londonderry, New Hampshire, United States | Recruiting |
| Catholic Medical Center | Manchester, New Hampshire, United States | Completed |
| Valley Hospital | Ridgewood, New Jersey, United States | Completed |
| Fondazione Centro San Raffaele | Milan, MI, Italy | Completed |
| Centre Hospitalier Princesse Grace | Monaco, Monaco | Completed |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03053141